KFDA approves 11 multinational clinical trials in July

Published: 2012-07-26 07:00:00

Updated: 2012-07-26 07:00:00

The Korea Food and Drug Administration said yesterday it approved 11 multinational clinical (MNC) trials for foreign-invested pharmaceutical firms, pointing to the rapid development of the local clinical experimentation sector.

The applications for such MNC trials were filed by the following multinational drug firms - Sanofi-Aventis (Phase I of teriflunomide and SAR125844), Novartis (Phase I...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.